May 21, 2026
Holding patients hostage: Why drug prices in the US are higher than ever
Rising drug costs are an increasingly important priority in the US. Americans spend more on healthcare than any other country…
May 18, 2026
SHARx Calls for Accountability as Policymakers Target PBM Practices Nationwide
Rising drug costs and persistent access barriers are prompting employers to scrutinize the role of PBMs in determining how care…
April 13, 2026
SHARx: Drug Pricing Isn’t Just Broken, It’s Protected
Growing regulatory scrutiny and industry reporting suggests that high drug prices persist not just because of cost, but because of…
March 24, 2026
SHARx Analyzes TrumpRx: Transparency on Drug Costs Doesn’t Resolve Pricing and Access Gatekeeping
The launch of the TrumpRx platform has put prescription drug pricing back in the spotlight, but lower list prices are…
March 18, 2026
Business Insight Journal Interview with Paul Pruitt, Co-founder and Chief Growth Officer at SHARx
Paul Pruitt, co-founder of SHARx, argues that the U.S. drug affordability crisis is driven by a lack of transparency and…
March 3, 2026
Reclaiming Affordability: A Sustainable Way to Deliver Prescription Benefits
This article, Paul Pruitt (CGO of SHARx) explores how opaque pharmacy pricing models continue to drive high prescription drug costs…
March 3, 2026
Providing Access to Uncovered Specialty Medications with Paul Pruitt (SHARx)
In this episode of the Empowered Patient Podcast, Paul Pruitt, CGO of SHARx, shares how rising specialty drug costs are putting…
February 24, 2026
Trump administration launches website to lower medication costs
The story discusses President Donald Trump’s TrumpRx.gov initiative to lower out-of-pocket drug costs through “most favored nation” pricing, primarily benefiting…
February 20, 2026
Weighing the Pros and Cons of New Drug Discount Website, TrumpRx
Ozarks First’s segment highlights TrumpRx.gov as a new White House prescription discount site featuring more than 40 medications and directing…
February 20, 2026
Trump Rx (2/16/2026)
Direct-to-consumer prescription platforms are operating by connecting patients directly with manufacturers, bypassing traditional insurance structures and pharmacy benefit managers. Removing…